{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 5
    }
  },
  "results": [
    {
      "discontinued_date": "01/13/2026",
      "update_type": "New",
      "initial_posting_date": "01/13/2026",
      "package_ndc": "61314-454-68",
      "generic_name": "Adalimumab-adaz Injection",
      "contact_info": "800-525-8747",
      "related_info": "Equivalent Sandoz format is available.",
      "openfda": {
        "application_number": [
          "BLA761071"
        ],
        "brand_name": [
          "HYRIMOZ"
        ],
        "generic_name": [
          "ADALIMUMAB-ADAZ"
        ],
        "manufacturer_name": [
          "Sandoz Inc"
        ],
        "product_ndc": [
          "61314-454",
          "61314-473",
          "61314-476",
          "61314-509",
          "61314-517",
          "61314-531"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "ADALIMUMAB"
        ],
        "rxcui": [
          "2641644",
          "2641650",
          "2641653",
          "2641654",
          "2641655",
          "2641658",
          "2641660",
          "2641661",
          "2641662",
          "2641663",
          "2641664",
          "2641665",
          "2641666",
          "2641667",
          "2641668",
          "2641669",
          "2641670",
          "2641671",
          "2641672",
          "2641673"
        ],
        "spl_id": [
          "48b7e44a-945f-487d-b2fd-3da13d6d6fdb"
        ],
        "spl_set_id": [
          "1ac7d061-3380-468c-b077-c05f8dfbc829"
        ],
        "package_ndc": [
          "61314-454-20",
          "61314-454-36",
          "61314-454-68",
          "61314-473-64",
          "61314-473-20",
          "61314-473-92",
          "61314-476-64",
          "61314-509-64",
          "61314-517-36",
          "61314-454-96",
          "61314-473-96",
          "61314-531-64",
          "61314-454-94",
          "61314-473-94"
        ],
        "nui": [
          "N0000175610",
          "N0000175451",
          "M0001357"
        ],
        "pharm_class_epc": [
          "Tumor Necrosis Factor Blocker [EPC]"
        ],
        "pharm_class_moa": [
          "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
        ],
        "pharm_class_cs": [
          "Antibodies, Monoclonal [CS]"
        ],
        "unii": [
          "FYS6T7F842"
        ]
      },
      "update_date": "01/13/2026",
      "therapeutic_category": [
        "Rheumatology"
      ],
      "dosage_form": "Injection",
      "presentation": "Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68)",
      "company_name": "Sandoz Inc.",
      "status": "To Be Discontinued"
    }
  ]
}